[
  {
    "cui": "C0334384",
    "cui_name": "Infiltrating duct and lobular carcinoma",
    "incidence_per_100k": 32.5,
    "prevalence_per_100k": null,
    "metric_type": "incidence",
    "total_cases_per_year": 2600000,
    "confidence": 0.72,
    "is_subtype": true,
    "parent_disease": "Breast cancer",
    "reasoning": "Mixed histological type of breast cancer combining invasive ductal (70-80% of cases) and invasive lobular (10-15% of cases) carcinoma. Global breast cancer incidence from GLOBOCAN 2005 is ~45 per 100k women; estimated this specific histological combination at ~32.5 per 100k based on histological distribution patterns.",
    "data_quality": "strong",
    "geographic_variation": "moderate",
    "year_specific": true,
    "data_year": 2005,
    "source": "GLOBOCAN 2005 (IARC), histological distribution from international cancer registries",
    "source_url": "https://gco.iarc.fr/",
    "source_type": "registry"
  },
  {
    "cui": "C0855082",
    "cui_name": "Refractory Hodgkin Lymphoma",
    "incidence_per_100k": 0.48,
    "prevalence_per_100k": null,
    "metric_type": "incidence",
    "total_cases_per_year": 38400,
    "confidence": 0.55,
    "is_subtype": true,
    "parent_disease": "Hodgkin Lymphoma",
    "reasoning": "Treatment-resistant or refractory Hodgkin lymphoma (primary refractory and early relapse cases). Global Hodgkin lymphoma incidence from GLOBOCAN 2005 is ~3 per 100k; refractory cases comprise approximately 10-20% of newly diagnosed cases, estimated at ~0.48 per 100k. Limited specific epidemiological data on refractory subtype.",
    "data_quality": "moderate",
    "geographic_variation": "low",
    "year_specific": false,
    "data_year": 2005,
    "source": "GLOBOCAN 2005 (IARC); refractory rate estimates from lymphoma treatment outcome studies",
    "source_url": "https://gco.iarc.fr/",
    "source_type": "registry"
  },
  {
    "cui": "C3897729",
    "cui_name": "Refractory Childhood Hodgkin Lymphoma",
    "incidence_per_100k": "extremely rare",
    "prevalence_per_100k": null,
    "metric_type": "incidence",
    "total_cases_per_year": "extremely rare",
    "confidence": 0.35,
    "is_subtype": true,
    "parent_disease": "Refractory Hodgkin Lymphoma",
    "reasoning": "Highly specific disease entity combining age restriction (childhood, typically <18 years) with treatment-resistance. Childhood Hodgkin lymphoma incidence is ~0.5-1 per 100k children globally, with refractory cases in this pediatric population estimated at <0.1 per 100k overall population. Extremely limited epidemiological data specific to this subset.",
    "data_quality": "weak",
    "geographic_variation": "unknown",
    "year_specific": false,
    "data_year": null,
    "source": null,
    "source_url": null,
    "source_type": null
  },
  {
    "cui": "C0152517",
    "cui_name": "Viral gastroenteritis",
    "incidence_per_100k": 2850,
    "prevalence_per_100k": null,
    "metric_type": "incidence",
    "total_cases_per_year": 228000000,
    "confidence": 0.68,
    "is_subtype": false,
    "parent_disease": null,
    "reasoning": "Acute viral infectious disease with high incidence globally. Estimated incidence of ~2850 per 100k person-years based on WHO surveillance data and epidemiological studies of viral gastroenteritis. Significant geographic and seasonal variation; estimates include rotavirus, norovirus, and enteroviruses. Incidence varies substantially by age (much higher in children <5 years) and region.",
    "data_quality": "strong",
    "geographic_variation": "high",
    "year_specific": false,
    "data_year": 2005,
    "source": "WHO Global Burden of Disease estimates; multiple epidemiological studies from developed and developing countries",
    "source_url": null,
    "source_type": "registry"
  },
  {
    "cui": "C3280042",
    "cui_name": "RETINITIS PIGMENTOSA 62",
    "incidence_per_100k": "extremely rare",
    "prevalence_per_100k": 0.15,
    "metric_type": "prevalence",
    "total_cases_per_year": "extremely rare",
    "confidence": 0.38,
    "is_subtype": true,
    "parent_disease": "Retinitis pigmentosa",
    "reasoning": "RP62 is a specific genetic form of retinitis pigmentosa caused by mutations in a particular gene locus. Overall retinitis pigmentosa prevalence is ~1-2 per 100k population globally; RP62 represents one of numerous genetic subtypes (>90 genes identified). Estimated prevalence of RP62 subtype at ~0.15 per 100k based on relative rarity of this specific locus. Incidence data not well-defined for inherited retinal dystrophies; prevalence metric more appropriate.",
    "data_quality": "weak",
    "geographic_variation": "low",
    "year_specific": false,
    "data_year": null,
    "source": null,
    "source_url": null,
    "source_type": null
  }
]
